Sex
Visit (Number) vs Psychomotor Vigilance Test (PVT) Median RT (msec)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Baseline (BL) | - | - | - | - | - | - | 1,516 | 1,516 |
| Clinical Evaluation (CE) | - | - | - | - | - | - | 1,516 | 1,516 |
| Diagnostic Visit (DX) | 1,199 | 249.5 | ± 63.0 | 246.0 | -888.0 | 758.0 | 317 | 1,516 |
| CPAP Titration Visit (CPAP) | - | - | - | - | - | - | 1,516 | 1,516 |
| Two Month Post-CPAP Neurocognitive Visit (2M) | 877 | 251.8 | ± 36.7 | 247.0 | -23.0 | 538.0 | 639 | 1,516 |
| Four Month Post-CPAP Neurocognitive Visit (4M) | - | - | - | - | - | - | 1,516 | 1,516 |
| Six Month Post-CPAP Neurocognitive Visit (6M) | 848 | 250.2 | ± 42.6 | 246.0 | -23.0 | 469.0 | 668 | 1,516 |
Gender vs Psychomotor Vigilance Test (PVT) Median RT (msec)
Baseline (BL)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | - | - | - | - | - | - | 1,516 | 1,516 |
| Male | - | - | - | - | - | - | 958 | 958 |
| Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Psychomotor Vigilance Test (PVT) Median RT (msec)
Clinical Evaluation (CE)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | - | - | - | - | - | - | 1,516 | 1,516 |
| Male | - | - | - | - | - | - | 958 | 958 |
| Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Psychomotor Vigilance Test (PVT) Median RT (msec)
Diagnostic Visit (DX)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,199 | 249.5 | ± 63.0 | 246.0 | -888.0 | 758.0 | 317 | 1,516 |
| Male | 767 | 243.5 | ± 59.1 | 239.0 | -888.0 | 758.0 | 191 | 958 |
| Female | 432 | 260.3 | ± 68.0 | 256.0 | -888.0 | 415.0 | 126 | 558 |
Gender vs Psychomotor Vigilance Test (PVT) Median RT (msec)
CPAP Titration Visit (CPAP)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | - | - | - | - | - | - | 1,516 | 1,516 |
| Male | - | - | - | - | - | - | 958 | 958 |
| Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Psychomotor Vigilance Test (PVT) Median RT (msec)
Two Month Post-CPAP Neurocognitive Visit (2M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 877 | 251.8 | ± 36.7 | 247.0 | -23.0 | 538.0 | 639 | 1,516 |
| Male | 569 | 245.5 | ± 34.3 | 241.0 | -23.0 | 538.0 | 389 | 958 |
| Female | 308 | 263.4 | ± 38.2 | 253.8 | 196.0 | 434.0 | 250 | 558 |
Gender vs Psychomotor Vigilance Test (PVT) Median RT (msec)
Four Month Post-CPAP Neurocognitive Visit (4M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | - | - | - | - | - | - | 1,516 | 1,516 |
| Male | - | - | - | - | - | - | 958 | 958 |
| Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Psychomotor Vigilance Test (PVT) Median RT (msec)
Six Month Post-CPAP Neurocognitive Visit (6M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 848 | 250.2 | ± 42.6 | 246.0 | -23.0 | 469.0 | 668 | 1,516 |
| Male | 550 | 244.4 | ± 40.8 | 241.8 | -23.0 | 469.0 | 408 | 958 |
| Female | 298 | 260.9 | ± 43.7 | 253.0 | -23.0 | 399.0 | 260 | 558 |
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Median RT (msec)
Baseline (BL)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | - | - | - | - | - | - | 1,516 | 1,516 |
| Native American | - | - | - | - | - | - | 28 | 28 |
| Asian | - | - | - | - | - | - | 89 | 89 |
| Black | - | - | - | - | - | - | 172 | 172 |
| Hispanic | - | - | - | - | - | - | 116 | 116 |
| White | - | - | - | - | - | - | 1,102 | 1,102 |
| Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Median RT (msec)
Clinical Evaluation (CE)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | - | - | - | - | - | - | 1,516 | 1,516 |
| Native American | - | - | - | - | - | - | 28 | 28 |
| Asian | - | - | - | - | - | - | 89 | 89 |
| Black | - | - | - | - | - | - | 172 | 172 |
| Hispanic | - | - | - | - | - | - | 116 | 116 |
| White | - | - | - | - | - | - | 1,102 | 1,102 |
| Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Median RT (msec)
Diagnostic Visit (DX)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,199 | 249.5 | ± 63.0 | 246.0 | -888.0 | 758.0 | 317 | 1,516 |
| Native American | 20 | 256.1 | ± 45.0 | 248.0 | 202.0 | 389.0 | 8 | 28 |
| Asian | 71 | 248.2 | ± 37.4 | 242.0 | 194.0 | 366.0 | 18 | 89 |
| Black | 115 | 249.9 | ± 46.8 | 246.0 | -23.0 | 401.0 | 57 | 172 |
| Hispanic | 83 | 255.1 | ± 64.4 | 242.0 | 201.0 | 758.0 | 33 | 116 |
| White | 902 | 249.0 | ± 66.8 | 246.0 | -888.0 | 620.0 | 200 | 1,102 |
| Other | 8 | 246.8 | ± 27.9 | 244.3 | 202.5 | 294.0 | 1 | 9 |
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Median RT (msec)
CPAP Titration Visit (CPAP)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | - | - | - | - | - | - | 1,516 | 1,516 |
| Native American | - | - | - | - | - | - | 28 | 28 |
| Asian | - | - | - | - | - | - | 89 | 89 |
| Black | - | - | - | - | - | - | 172 | 172 |
| Hispanic | - | - | - | - | - | - | 116 | 116 |
| White | - | - | - | - | - | - | 1,102 | 1,102 |
| Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Median RT (msec)
Two Month Post-CPAP Neurocognitive Visit (2M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 877 | 251.8 | ± 36.7 | 247.0 | -23.0 | 538.0 | 639 | 1,516 |
| Native American | 13 | 266.2 | ± 36.8 | 259.5 | 215.0 | 362.5 | 15 | 28 |
| Asian | 48 | 247.5 | ± 36.6 | 241.0 | 192.0 | 395.5 | 41 | 89 |
| Black | 76 | 250.7 | ± 37.6 | 243.8 | 174.0 | 402.0 | 96 | 172 |
| Hispanic | 65 | 259.2 | ± 52.8 | 250.0 | 194.0 | 538.0 | 51 | 116 |
| White | 672 | 251.1 | ± 34.7 | 246.8 | -23.0 | 434.0 | 430 | 1,102 |
| Other | 3 | 277.7 | ± 14.0 | 277.0 | 264.0 | 292.0 | 6 | 9 |
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Median RT (msec)
Four Month Post-CPAP Neurocognitive Visit (4M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | - | - | - | - | - | - | 1,516 | 1,516 |
| Native American | - | - | - | - | - | - | 28 | 28 |
| Asian | - | - | - | - | - | - | 89 | 89 |
| Black | - | - | - | - | - | - | 172 | 172 |
| Hispanic | - | - | - | - | - | - | 116 | 116 |
| White | - | - | - | - | - | - | 1,102 | 1,102 |
| Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Median RT (msec)
Six Month Post-CPAP Neurocognitive Visit (6M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 848 | 250.2 | ± 42.6 | 246.0 | -23.0 | 469.0 | 668 | 1,516 |
| Native American | 13 | 261.6 | ± 45.4 | 248.0 | 217.0 | 388.0 | 15 | 28 |
| Asian | 50 | 242.9 | ± 51.8 | 242.3 | -23.0 | 382.5 | 39 | 89 |
| Black | 75 | 250.2 | ± 53.0 | 251.5 | -23.0 | 469.0 | 97 | 172 |
| Hispanic | 61 | 251.0 | ± 52.8 | 246.0 | -23.0 | 415.0 | 55 | 116 |
| White | 646 | 250.4 | ± 39.4 | 246.0 | -23.0 | 426.0 | 456 | 1,102 |
| Other | 3 | 268.0 | ± 6.6 | 269.0 | 261.0 | 274.0 | 6 | 9 |